Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Health Review.
Press releases published on July 1, 2025

Stier Beratung Reimagines Digital Transformation with Unrivaled Expertise, Global Delivery and Talent Development
Stier Beratung drives digital transformation, talent, AI, and GCCs for DACH mid-sized firms, with strategy-to-execution model and sustainability services. NUREMBERG, BAYERN, GERMANY, July 1, 2025 /EINPresswire.com/ -- Stier Beratung GmbH, a leading …

TRANSFORMING.LEGAL Launches Free Access to GOLT.ai
Semantic AI-Powered Search Now Available for one of the World’s Leading Legaltech Platforms SINGAPORE, SINGAPORE, July 1, 2025 /EINPresswire.com/ -- In a bold move to eliminate barriers to legal innovation, TRANSFORMING.LEGAL, the global transformation …

The Hidden Drawbacks of HIV: Treatment Regimens may Exacerbate Risk of Knee Arthritis
A prominent class of drugs used for HIV management may accelerate osteoarthritis development CHENGDU, SICHUAN, CHINA, July 1, 2025 /EINPresswire.com/ -- Improved treatment regimens have increased the life expectancy of individuals infected with HIV. …

SOMAÍ and Lusófona Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
LISBON, PORTUGAL, July 1, 2025 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, in collaboration with Lusófona University, the largest Portuguese …

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of USD 222 billion over next 10 years Ongoing investment in in-house manufacturing to create end-to-end …

atai Life Sciences Announces $50 Million Private Placement Financing
NEW YORK and AMSTERDAM, July 01, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, today …

atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
Study met its primary and all key secondary endpoints, and BPL-003 demonstrated rapid, robust and durable antidepressant effects with a single dose Both 8 mg and 12 mg single doses of BPL-003 showed statistically significant and clinically meaningful …